Journal of Clinical Microbiology, September 1998, p. 2795-2796, Vol. 36, No. 9
0095-1137/98/$00.00+0
LETTERS TO THE EDITOR
Serological Investigation of a Febrile Outbreak in Delhi,
India, Using a Rapid Immunochromatographic Test
 |
LETTER |
In reference to the article by Vaughn et al. published in the
January 1998 issue (6), we have also used the rapid
immunochromatographic assay for detection of dengue immunoglobulin M
(IgM) and IgG antibodies (PanBio, Brisbane, Australia) in the serologic
evaluation of a febrile outbreak in Delhi, India, in 1997. India has
witnessed dengue epidemics since the last century, but cases with
hemorrhagic manifestations appeared in Calcutta in 1963 (5)
and in Delhi in 1988, followed by dengue hemorrhagic fever (DHF)
epidemics in Shahjahanpur, Surat, and Calcutta in the 1990s (1,
3). Delhi had another epidemic of DHF in 1996.
A total of 189 acute-phase serum samples collected at a
tertiary-care hospital from April to December 1997 were
screened for the presence of antidengue IgM and IgG antibodies by the
rapid immunochromatographic test. The results for 43 randomly selected serum samples were compared with results obtained by the Dengue Duo IgM
and IgG capture enzyme-linked immunosorbent assay (ELISA) (PanBio), as
shown in Table 1. The results of the
rapid immunochromatographic test were graded as reactive (strong band
seen), weakly reactive (faint band seen), or negative (no band seen). A
total of 31 patients had evidence of dengue fever (including DHF-dengue
shock syndrome [DHF-DSS]). Of these patients, 4 had primary infection
and 27 had secondary dengue. About 50% of DHF cases were seen in the age group below 15 years, unlike the situation with earlier
epidemics, in which DHF mostly affected children and 95% of cases
reported occurred in the age group below 15 years (2, 4).
DSS occurred in four patients, three of whom were less than 15 years
old. The mean age of the patients with evidence of antidengue
antibodies was 21.5 years. Adults comprised 67.8% of the serologically
confirmed dengue cases. The maximum number of cases occurred in
the 11- to 15-year age group (32.2%), followed by the 21- to
25-year age group (29%). The maximum number of cases occurred in the
month of October.
View this table:
[in this window]
[in a new window]
|
TABLE 1.
Comparison of results of rapid immunochromatographic
assay with those of capture ELISA for IgM and
IgG antibodiesa
|
|
For those sera showing weakly reactive results by the initial rapid
test, the capture ELISA was found useful. Since virus isolation takes a long time, serology is carried out in most
laboratories for rapid diagnosis of dengue infection. The rapid
immunochromatographic assay takes 5 min only and is a useful screening
test. A combination of this test with the IgM and IgG capture ELISA
should be used for final serologic diagnosis and distinguishing between
primary and secondary dengue infections.
 |
REFERENCES |
| 1.
|
Banerjee, K.
1996.
Emerging viral infections with special reference to India.
Indian J. Med. Res.
105:177-200.
|
| 2.
|
Bang, Y. H.
1985.
Number of reported cases of DHF and deaths in Burma, Indonesia and Thailand, 1958-1984.
Dengue Newsl.
11:5.
|
| 3.
|
Bhattacharjee, N.,
K. K. Mukherjee,
S. K. Chakravarti, et al.
1993.
Dengue haemorrhagic fever outbreak in Calcutta 1990.
J. Commun. Dis.
25:10-14[Medline].
|
| 4.
|
Jatanasen, S.,
P. Skuntanaga, and C. Dhanasiri.
1962.
Some aspects of epidemiology of Thai haemorrhagic fever 1958-1961, p. 6-21.
In
Symposium on haemorhagic fever. SEATO medical research monograph no. 2. Post Publishing Co. Ltd., Bangkok, Thailand.
|
| 5.
|
Sarkar, J. K.,
K. M. Pavri,
S. N. Chatterjee, et al.
1964.
Virological and serological studies of cases of haemorrhagic fever in Calcutta. Material collected by the Calcutta School of Tropical Medicine.
Indian J. Med. Res.
52:684-691[Medline].
|
| 6.
|
Vaughn, D. W.,
A. Nisalak,
S. Kalayanarooj,
T. Solomon,
N. M. Dung,
A. Cuzzubbo, and P. L. Devine.
1998.
Evaluation of a rapid immunochromatographic test for diagnosis of dengue virus infection.
J. Clin. Microbiol.
36:234-238[Abstract/Free Full Text].
|
| | | | |
N. Berry
A. Chakravarti
R. Gur
M. D. Mathur
Department of Microbiology Maulana Azad Medical College New Delhi, India
|
 |
AUTHOR'S REPLY |
My colleagues and I thank Drs. Berry, Chakravarti, Gur, and Mathur for
their letter describing their experience with the Dengue Rapid Test (an
immunochromatographic assay produced by PanBio, Brisbane, Australia)
and the Dengue Duo ELISA (PanBio). They tested single specimens from
189 patients with the rapid test. A subset of 43 specimens were
selected randomly from samples taken at the height of the dengue season
and tested for antidengue IgM and IgG antibodies with the Duo ELISA
(Table 1). Compared to the ELISA, the
sensitivity for the rapid test was 100% (as also reported in our
paper) while the specificity was just 55% (versus 88% in our study
using in-house antibody assays with paired sera and virus isolation as
the criterion standard). Other recent evaluations of the rapid test
have demonstrated test specificity consistent with our findings with
paired sera lacking antibody against dengue viruses by the
hemagglutination assay: 96% specificity with 23 paired serum specimens
(2) and 90% specificity with 30 paired serum specimens
(1).
View this table:
[in this window]
[in a new window]
|
TABLE 1.
Results of testing 43 randomly selected single serum
specimens from suspected-dengue patients by the Dengue Duo ELISA
and the Dengue Rapid immunochromatographic test
|
|
There are a few possible explanations for the lower specificity
reported by Dr. Berry et al. An important weakness in their study is
that no convalescent-phase specimens were collected and tested. A
second specimen collected a week or two following the onset of illness
is needed to show that specimens collected at the time of admission and
negative by the ELISA were truly negative. It may be that follow-up
testing with the ELISA would confirm the early positive findings of the
rapid test for some specimens thought to represent false positives. A
second possibility is that some of the illnesses were caused by
flaviviruses other than dengue viruses and that the rapid test was more
likely to give false-positive results for the presence of anti-dengue
virus antibody. In our study, the rapid test demonstrated a specificity
of just 50% when used to test sera from patients with Japanese
encephalitis. Japanese encephalitis and West Nile virus cocirculate
with dengue viruses in India, and cross-reactive antibody may have
produced some false-positive results. Lastly, we noted in our
evaluation of the rapid test that false-positive lines may occur if the
test is read some time after the suggested time of 5 min.
To conclude, false-positive assay results are a concern as a clinician
may discount other potential etiologies for which a specific
intervention is available, to the detriment of the patient. Care is
required in the interpretation of any antibody test, but especially
with dengue where antibodies rise relatively late in the course of the
illness. Another potential problem is for a health care provider to
interpret a negative serologic result early in the course of illness as
meaning the patient is not experiencing dengue disease and to fail to
warn the patient or parents about the signs of impending shock.
Additional evaluations of the newer rapid dengue assays using paired
sera should be encouraged, along with studies of the effects that the
availability of 7-min assays such as the PanBio Dengue Rapid Test may
have on the clinical management of patients experiencing dengue
illness.
 |
REFERENCES |
| 1.
| Lam, S. K., and P. L. Devine.
Evaluation of capture ELISA and rapid immunochromatographic test for
the determination of IgM and IgG antibodies produced during dengue
infection. Clin. Diagn. Virol., in press.
|
| 2.
|
Sang, C. T.,
L. S. Hoon,
A. Cuzzubbo, and P. L. Devine.
1998.
Clinical evaluation of a rapid immunochromatographic test for the diagnosis of dengue virus infection.
Clin. Diagn. Lab. Immunol.
5:407-409[Abstract].
|
| | | | |
David W. Vaughn
Department of Virus Diseases Walter Reed Army Institute of Research Washington, DC 20307-5100
|
Journal of Clinical Microbiology, September 1998, p. 2795-2796, Vol. 36, No. 9
0095-1137/98/$00.00+0